• It is accessible, available in
different ways, and puts more
control in patient’s hands
FORMING ROOTS IN THE CANNABIS
When it comes to launching into the cannabis
industry, Bocskor said that the greatest struggle among the majority of the companies he
works with comes from the capital formation
process, which is largely due to the changing
regulatory environments from state to state.
“If you’re going to be in the legal cannabis
industry, it is completely different in each of
the jurisdictions,” said Bocskor. “If you are
not getting the right information and don’t
know what’s going on, you’re going to be heading towards failure.
“If you know the market, it opens up a world of possi-
bility for you.”
Companies looking to enter the cannabis market often
face a series of questions:
• What state should they launch the company in?
• How do they get the capital to start the company?
• What is the best way to form a company?
• How do they find partners?
• How do they find people to help them with regulatory
concerns from state to state?
• How do they go about finding investors? (Particularly
when cannabis is still federally illegal.)
“We work with them on their overarching strategy and
make modifications to the strategy that we think will help
them succeed in an expedited fashion,” Bocskor explained.
Don’t be ready for the market as it
is today, but for as it will be tomorrow, said Bocskor.
“If you want to be in the industry,
reach out to people in the indus-
try,” he said, “because if you’re not
knowledgeable, you’re never going
to get in it.”
Some of the disease states that
medical cannabis has the potential
to significantly impact, according
to Bocskor, include, but are not
• Pain management
• Seizure disorders
• Brain trauma
• Managing type 2 diabetes
THEN VS. NOW
“Seven or eight years ago, marijuana was a very taboo
subject,” said Evan Nison, Co-Founder and Director of the
NY Cannabis Alliance. “The majority of Americans support
taxing and regulating the cannabis industry.”
According to one poll by Gallup, American’s support
for legal marijuana has grown steadily over time: from 34
percent supporting marijuana legalization in 2001 to 58
percent in 2015.2
“I think medical marijuana is going to become very
industrialized in the pharmaceutical industry and will be
nearly indistinguishable from other medications that we
consume now on a daily basis,” said Nison. “I also see
hemp becoming a major industry by creating biodegrad-
able plastics, rope, cloth, clothing, cars, concrete—it’s
a sustainable, environmentally-friendly alternative to
a lot of materials that we are
But the U.S. isn’t the only
country making headway into
the cannabis industry.
“Canada has a thriving underground
cannabis economy,” said Neil Belot,
Chief Brand Officer of Aurora, a
medical marijuana producer and
distributor. “Five years ago, there
was little legal ‘industry’ to speak of
aside from some licensed personal/
caregiver production and one com-
mercial supply option through a sin-
gle government contractor.”
Although the prohibition currently
stands in Canada, Justin Trudeau,
Prime Minister of Canada, has an-
INTERPHEX 2016 www.pharmpro.com 17
TUESDAY ■ APRIL 26 ■ 2016 TUESDAY ■ APRIL 26 ■ 2016